Concepedia

Volker Gekeler

VG

Statistics

Publications

70

Citations

5.2K

H-Index

36

Active since

1980

Affiliations

University of Tübingen(Current)

Charité - Universitätsmedizin Berlin

Klinikum Konstanz

University Children's Hospital Tübingen

Altana (Germany)

Volker Gekeler is an author at University of Tübingen specializing in medicine, molecular oncology, and oncology.

Publications per year

1980–2016

70

Publications

70

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

Wilko Weichert, A.-E. Roske, Volker Gekeler et al. · British Journal of Cancer · 2008 · 479 citations · Full text

, , +17

The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug Resistance

Volker Gekeler, W Ise, Karl H. Sanders et al. · Biochemical and Biophysical Research Communications · 1995 · 406 citations

, , +8

Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases <i>In vitro</i> and <i>In vivo</i>

Wilko Weichert, A.-E. Roske, Silvia Niesporek et al. · Clinical Cancer Research · 2008 · 371 citations

, , +15

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis

Wilko Weichert, A.-E. Roske, Volker Gekeler et al. · The Lancet Oncology · 2008 · 362 citations

, , +16

Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells.

Astrid Kimmig, Volker Gekeler, Manfred Neumann et al. · PubMed · 1990 · 200 citations

, , +12

1–5 of 70